Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.

Chagas disease, caused by Trypanosoma cruzi, is endemic in southern parts of the American continent. Herein, we have tested the protective efficacy of a DNA-prime/T. rangeli-boost (TcVac4) vaccine in a dog (Canis familiaris) model. Dogs were immunized with two-doses of DNA vaccine (pcDNA3.1 encoding...

Full description

Bibliographic Details
Main Authors: José E Aparicio-Burgos, José A Zepeda-Escobar, Roberto Montes de Oca-Jimenez, José G Estrada-Franco, Alberto Barbabosa-Pliego, Laucel Ochoa-García, Ricardo Alejandre-Aguilar, Nancy Rivas, Giovanna Peñuelas-Rivas, Margarita Val-Arreola, Shivali Gupta, Felix Salazar-García, Nisha J Garg, Juan C Vázquez-Chagoyán
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-04-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4390229?pdf=render
_version_ 1818527337760686080
author José E Aparicio-Burgos
José A Zepeda-Escobar
Roberto Montes de Oca-Jimenez
José G Estrada-Franco
Alberto Barbabosa-Pliego
Laucel Ochoa-García
Ricardo Alejandre-Aguilar
Nancy Rivas
Giovanna Peñuelas-Rivas
Margarita Val-Arreola
Shivali Gupta
Felix Salazar-García
Nisha J Garg
Juan C Vázquez-Chagoyán
author_facet José E Aparicio-Burgos
José A Zepeda-Escobar
Roberto Montes de Oca-Jimenez
José G Estrada-Franco
Alberto Barbabosa-Pliego
Laucel Ochoa-García
Ricardo Alejandre-Aguilar
Nancy Rivas
Giovanna Peñuelas-Rivas
Margarita Val-Arreola
Shivali Gupta
Felix Salazar-García
Nisha J Garg
Juan C Vázquez-Chagoyán
author_sort José E Aparicio-Burgos
collection DOAJ
description Chagas disease, caused by Trypanosoma cruzi, is endemic in southern parts of the American continent. Herein, we have tested the protective efficacy of a DNA-prime/T. rangeli-boost (TcVac4) vaccine in a dog (Canis familiaris) model. Dogs were immunized with two-doses of DNA vaccine (pcDNA3.1 encoding TcG1, TcG2, and TcG4 antigens plus IL-12- and GM-CSF-encoding plasmids) followed by two doses of glutaraldehyde-inactivated T. rangeli epimastigotes (TrIE); and challenged with highly pathogenic T. cruzi (SylvioX10/4) isolate. Dogs given TrIE or empty pcDNA3.1 were used as controls. We monitored post-vaccination and post-challenge infection antibody response by an ELISA, parasitemia by blood analysis and xenodiagnosis, and heart function by electrocardiography. Post-mortem anatomic and pathologic evaluation of the heart was conducted. TcVac4 induced a strong IgG response (IgG2>IgG1) that was significantly expanded post-infection, and moved to a nearly balanced IgG2/IgG1 response in chronic phase. In comparison, dogs given TrIE or empty plasmid DNA only developed high IgG titers with IgG2 predominance in response to T. cruzi infection. Blood parasitemia, tissue parasite foci, parasite transmission to triatomines, electrocardiographic abnormalities were significantly lower in TcVac4-vaccinated dogs than was observed in dogs given TrIE or empty plasmid DNA only. Macroscopic and microscopic alterations, the hallmarks of chronic Chagas disease, were significantly decreased in the myocardium of TcVac4-vaccinated dogs. We conclude that TcVac4 induced immunity was beneficial in providing resistance to T. cruzi infection, evidenced by control of chronic pathology of the heart and preservation of cardiac function in dogs. Additionally, TcVac4 vaccination decreased the transmission of parasites from vaccinated/infected animals to triatomines.
first_indexed 2024-12-11T06:34:48Z
format Article
id doaj.art-46dfa7ef598844e58576188c53aaa662
institution Directory Open Access Journal
issn 1935-2727
1935-2735
language English
last_indexed 2024-12-11T06:34:48Z
publishDate 2015-04-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj.art-46dfa7ef598844e58576188c53aaa6622022-12-22T01:17:24ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352015-04-0194e000362510.1371/journal.pntd.0003625Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.José E Aparicio-BurgosJosé A Zepeda-EscobarRoberto Montes de Oca-JimenezJosé G Estrada-FrancoAlberto Barbabosa-PliegoLaucel Ochoa-GarcíaRicardo Alejandre-AguilarNancy RivasGiovanna Peñuelas-RivasMargarita Val-ArreolaShivali GuptaFelix Salazar-GarcíaNisha J GargJuan C Vázquez-ChagoyánChagas disease, caused by Trypanosoma cruzi, is endemic in southern parts of the American continent. Herein, we have tested the protective efficacy of a DNA-prime/T. rangeli-boost (TcVac4) vaccine in a dog (Canis familiaris) model. Dogs were immunized with two-doses of DNA vaccine (pcDNA3.1 encoding TcG1, TcG2, and TcG4 antigens plus IL-12- and GM-CSF-encoding plasmids) followed by two doses of glutaraldehyde-inactivated T. rangeli epimastigotes (TrIE); and challenged with highly pathogenic T. cruzi (SylvioX10/4) isolate. Dogs given TrIE or empty pcDNA3.1 were used as controls. We monitored post-vaccination and post-challenge infection antibody response by an ELISA, parasitemia by blood analysis and xenodiagnosis, and heart function by electrocardiography. Post-mortem anatomic and pathologic evaluation of the heart was conducted. TcVac4 induced a strong IgG response (IgG2>IgG1) that was significantly expanded post-infection, and moved to a nearly balanced IgG2/IgG1 response in chronic phase. In comparison, dogs given TrIE or empty plasmid DNA only developed high IgG titers with IgG2 predominance in response to T. cruzi infection. Blood parasitemia, tissue parasite foci, parasite transmission to triatomines, electrocardiographic abnormalities were significantly lower in TcVac4-vaccinated dogs than was observed in dogs given TrIE or empty plasmid DNA only. Macroscopic and microscopic alterations, the hallmarks of chronic Chagas disease, were significantly decreased in the myocardium of TcVac4-vaccinated dogs. We conclude that TcVac4 induced immunity was beneficial in providing resistance to T. cruzi infection, evidenced by control of chronic pathology of the heart and preservation of cardiac function in dogs. Additionally, TcVac4 vaccination decreased the transmission of parasites from vaccinated/infected animals to triatomines.http://europepmc.org/articles/PMC4390229?pdf=render
spellingShingle José E Aparicio-Burgos
José A Zepeda-Escobar
Roberto Montes de Oca-Jimenez
José G Estrada-Franco
Alberto Barbabosa-Pliego
Laucel Ochoa-García
Ricardo Alejandre-Aguilar
Nancy Rivas
Giovanna Peñuelas-Rivas
Margarita Val-Arreola
Shivali Gupta
Felix Salazar-García
Nisha J Garg
Juan C Vázquez-Chagoyán
Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
PLoS Neglected Tropical Diseases
title Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
title_full Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
title_fullStr Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
title_full_unstemmed Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
title_short Immune protection against Trypanosoma cruzi induced by TcVac4 in a canine model.
title_sort immune protection against trypanosoma cruzi induced by tcvac4 in a canine model
url http://europepmc.org/articles/PMC4390229?pdf=render
work_keys_str_mv AT joseeaparicioburgos immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT joseazepedaescobar immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT robertomontesdeocajimenez immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT josegestradafranco immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT albertobarbabosapliego immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT laucelochoagarcia immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT ricardoalejandreaguilar immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT nancyrivas immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT giovannapenuelasrivas immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT margaritavalarreola immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT shivaligupta immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT felixsalazargarcia immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT nishajgarg immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel
AT juancvazquezchagoyan immuneprotectionagainsttrypanosomacruziinducedbytcvac4inacaninemodel